GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 72 filers reported holding GOSSAMER BIO INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 200 | +98.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 101 | -99.8% | 0.00% | – |
| Q1 2023 | $52 | -98.3% | 41,580 | -97.1% | 0.00% | -100.0% |
| Q4 2022 | $3,109 | -99.8% | 1,432,620 | +838.5% | 0.00% | -50.0% |
| Q3 2022 | $1,830,000 | +4363.4% | 152,649 | +2965.9% | 0.00% | – |
| Q2 2022 | $41,000 | -97.5% | 4,979 | -96.6% | 0.00% | – |
| Q4 2021 | $1,638,000 | +1402.8% | 144,900 | +979.0% | 0.00% | – |
| Q2 2021 | $109,000 | +2080.0% | 13,429 | +2657.5% | 0.00% | – |
| Q1 2021 | $5,000 | -98.1% | 487 | -98.2% | 0.00% | – |
| Q4 2020 | $268,000 | -60.9% | 27,721 | -47.4% | 0.00% | -100.0% |
| Q2 2020 | $685,000 | +6750.0% | 52,714 | +5340.0% | 0.00% | – |
| Q1 2020 | $10,000 | – | 969 | +10666.7% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 9 | -100.0% | 0.00% | -100.0% |
| Q3 2019 | $1,447,000 | +2027.9% | 86,197 | +2646.9% | 0.00% | – |
| Q1 2019 | $68,000 | – | 3,138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |